Table 3.
Anatomic Site and Summary Stage at Diagnosis for Cancer Cohort Members by Sex
|
Total (N = 65,225) |
Females (N = 36,492) |
Males (N = 28,733) |
|||
| Anatomic Site | N | N | % | N | % |
| Breast | 15,080 | 14,962 | 99% | 118 | 1% |
| Prostate | 10,509 | 10,509 | 100% | ||
| Melanoma | 9048 | 4280 | 47% | 4768 | 53% |
| Colorectal | 4717 | 2386 | 51% | 2331 | 49% |
| Head and Neck | 3055 | 1615 | 53% | 1440 | 47% |
| Leukemia | 3042 | 1343 | 44% | 1699 | 56% |
| Lung | 2917 | 1661 | 57% | 1256 | 43% |
| Bladder | 2416 | 538 | 22% | 1878 | 78% |
| Cervical | 2212 | 2212 | 100% | ||
| Endometrial | 1994 | 1994 | 100% | ||
| Lymphoma | 1751 | 869 | 50% | 882 | 50% |
| Kidney and Ureter | 1562 | 569 | 36% | 993 | 64% |
| Brain and Other Nervous System | 1550 | 1006 | 65% | 544 | 35% |
| Pancreatic and Biliary | 1371 | 651 | 47% | 720 | 53% |
| Upper Gastrointestinal Tract | 991 | 345 | 35% | 646 | 65% |
| Othera | 3010 | 2061 | 68% | 949 | 32% |
|
Total (N = 65,225) |
Females (N = 36,492) |
Males (N = 28,733) |
|||
| Summary Stageb | N | N | % | N | % |
| In-Situ | 10,261 | 6897 | 19% | 3364 | 12% |
| Local | 32,354 | 16,864 | 46% | 15,490 | 54% |
| Regional | 10,243 | 6256 | 17% | 3987 | 14% |
| Distant | 7951 | 3893 | 11% | 4058 | 14% |
| Benign/Borderline | 1263 | 855 | 2% | 408 | 1% |
| Unknown | 1983 | 981 | 3% | 1002 | 4% |
| Missing | 1170 | 746 | 2% | 424 | 1% |
aOther includes cancers of the following systems and sites: eye, musculoskeletal, genitourinary otherwise not listed, gynecologic otherwise not listed, condition-specific sarcomas, and unspecified/unknown cancers. bSEER general summary stage [8]